Other TNBC tumours with high RB expression, androgen receptor positivity, or associated clinical characteristics are also considered potential candidates [43] and some pre-clinical research suggests a benefit of combination treatment including CDK4/6 inhibition [41]. This evidence concerns the gene CDK4 and neoplasm.